Last $39.38 USD
Change Today +0.57 / 1.47%
Volume 639.8K
LCI On Other Exchanges
Symbol
Exchange
New York
Frankfurt
As of 8:04 PM 08/29/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

G. Michael Landis

Chief Accounting Officer and Director of Financial Reporting, Lannett Company, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

48--

Background*

Mr. G. Michael Landis has been Principal Accounting Officer at Lannett Company, Inc since April 24, 2012 and serves as its Director of Financial Reporting. Mr. Landis has been an Employee and Financial Consultant at Lannett since April 2009. Mr. Landis served as Director of Financial Reporting at Lannett. Prior to joining Lannett, from October 2007 to December 2008, he served as Corporate Controller at Akrion, Inc. From 2002 to 2007, Mr. Landis served as Director of ...

Read Full Background

Corporate Headquarters*

9000 State Road
Philadelphia, Pennsylvania 19136

United States

Phone: 215-333-9000
Fax: --

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

BA
Franklin & Marshall College

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
LCI:US $39.38 USD +0.57

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Friedhelm Blobel Ph.D.Chief Executive Officer, President, Executive Director and Member of Business Development Committee
SciClone Pharmaceuticals, Inc.
$550.0K
Samuel M. Inman IIIChief Executive Officer, President and Director
Covisint Corporation
$23.2K
Craig A. Wheeler Chief Executive Officer, President and Executive Director
Momenta Pharmaceuticals Inc.
$621.0K
A. J. Kazimi MBAFounder, Chairman, Chief Executive Officer and President
Cumberland Pharmaceuticals, Inc.
$620.0K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact LANNETT CO INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.